Mixed matrix hollow fiber membranes for removal of protein-bound toxins from human plasma

Biomaterials

Volumn 34, Issue 32, 2013, Pages 7819-7828

  Tijink, Marlon S L ^a   Wester, Maarten ^c   Glorieux, Griet ^d   Gerritsen, Karin G F ^c   Sun, Junfen ^a   Swart, Pieter C ^a   Borneman, Zandrie ^b   Wessling, Matthias ^e   Vanholder, Raymond ^d   Joles, Jaap A ^c   Stamatialis, Dimitrios ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Catholic University College Gent   (Belgium)

^e RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Blood purification; Hollow fibers; Mixed matrix membranes; Removal of uremic toxins

Indexed keywords

BLOOD PURIFICATION; DIFFUSION EXPERIMENTS; END STAGE RENAL DISEASE; HOLLOW FIBER; HOLLOW FIBER MEMBRANES; MIXED MATRIX MEMBRANES; RENAL REPLACEMENT THERAPIES; UREMIC TOXINS;

ACTIVATED CARBON; EXPERIMENTS; FIBERS; METABOLITES; PLASMA (HUMAN); PROTEINS; TOXIC MATERIALS;

MEMBRANES;

4 CRESYLSULFATE; HIPPURIC ACID; INDICAN; PROTEIN BOUND TOXIN; SULFATE; TOXIN; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL MEMBRANE; HOLLOW FIBER MEMBRANE; MEMBRANE TRANSPORT; MIXED MATRIX MEMBRANE; PLASMA; PRIORITY JOURNAL; ULTRAFILTRATION;

EID: 84881026236     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.008     Document Type: Article

References (49)

1. Coresh J., Selvin E., Stevens L.A., Manzi J., Kusek J.W., Eggers P., et al. Prevalence of chronic kidney disease in the United States. JAm Med Assoc 2007, 298:2038-2047.
2. Hamer R.A., El Nahas A.M. The burden of chronic kidney disease. Br Med J 2006, 332:563-564.
3. Szczech L.A., Lazar I.L. Projecting the United States ESRD population: issues regarding treatment of patients with ESRD. Kidney Int Suppl 2004, 66.
4. Kerr M., Bray B., Medcalf J., O'Donoghue D.J., Matthews B. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant 2012, 27:73-80.
5. Lacson E., Xu J., Suri R.S., Nesrallah G., Lindsay R., Garg A.X., et al. Survival with three-times weekly in-center nocturnal versus conventional hemodialysis. JAm Soc Nephrol 2012, 23:687-695.
6. Grooteman M.P.C., Van Den Dorpel M.A., Bots M.L., Penne E.L., Van Der Weerd N.C., Mazairac A.H.A., et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. JAm Soc Nephrol 2012, 23:1087-1096.
7. Mazairac A.H.A., De Wit G.A., Penne E.L., Van Der Weerd N.C., De Jong B., Grooteman M.P.C., et al. Changes in quality of life over time - Dutch haemodialysis patients and general population compared. Nephrol Dial Transplant 2011, 26:1984-1989.
8. Duranton F., Cohen G., De Smet R., Rodriguez M., Jankowski J., Vanholder R., et al. Normal and pathologic concentrations of uremic toxins. JAm Soc Nephrol 2012, 23:1258-1270.
9. Bammens B., Evenepoel P., Keuleers H., Verbeke K., Vanrenterghem Y. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 2006, 69:1081-1087.
10. Cheung A.K., Rocco M.V., Yan G., Leypoldt J.K., Levin N.W., Greene T., et al. Serum β-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. JAm Soc Nephrol 2006, 17:546-555.
11. Ito S., Osaka M., Higuchi Y., Nishijima F., Ishii H., Yoshida M. Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of e-selectin. JBiol Chem 2010, 285:38869-38875.
12. Adijiang A., Goto S., Uramoto S., Nishijima F., Niwa T. Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Nephrol Dial Transplant 2008, 23:1892-1901.
13. Lin C.J., Pan C.F., Liu H.L., Chuang C.K., Jayakumar T., Wang T.J., et al. The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis. Atherosclerosis 2012, 225:173-179.
14. Wu I.W., Hsu K.H., Lee C.C., Sun C.Y., Hsu H.J., Tsai C.J., et al. p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol Dial Transplant 2011, 26:938-947.
15. Itoh Y., Ezawa A., Kikuchi K., Tsuruta Y., Niwa T. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production. Anal Bioanal Chem 2012, 403:1841-1850.
16. Lekawanvijit S., Adrahtas A., Kelly D.J., Kompa A.R., Wang B.H., Krum H. Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?. Eur Heart J 2010, 31:1771-1779.
17. Adijiang A., Higuchi Y., Nishijima F., Shimizu H., Niwa T. Indoxyl sulfate, a uremic toxin, promotes cell senescence in aorta of hypertensive rats. Biochem Biophys Res Commun 2010, 399:637-641.
18. Saran R., Bragg-Gresham J.L., Levin N.W., Twardowski Z.J., Wizemann V., Saito A., et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006, 69:1222-1228.
19. Basile C., Libutti P., Di Turo A.L., Casino F.G., Vernaglione L., Tundo S., et al. Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis. Nephrol Dial Transplant 2011, 26:1296-1303.
20. Dhondt A., Vanholder R., Van Biesen W., Lameire N. The removal of uremic toxins. Kidney Int Suppl 2000, 58:S47-S59.
21. Meert N., Waterloos M.A., Van Landschoot M., Dhondt A., Ledebo I., Glorieux G., et al. Prospective evaluation of the change of predialysis protein-bound uremic solute concentration with postdilution online hemodiafiltration. Artif Organs 2010, 34:580-585.
22. Meyer T.W., Peattie J.W.T., Miller J.D., Dinh D.C., Recht N.S., Walther J.L., et al. Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate. JAm Soc Nephrol 2007, 18:868-874.
23. Patzer J. Principles of bound solute dialysis. Ther Apher Dial 2006, 10:118-124.
24. Dinh D.C., Recht N.S., Hostetter T.H., Meyer T.W. Coated carbon hemoperfusion provides limited clearance of protein-bound solutes. Artif Organs 2008, 32:717-724.
25. Sirich T.L., Luo F.J.G., Plummer N.S., Hostetter T.H., Meyer T.W. Selectively increasing the clearance of protein-bound uremic solutes. Nephrol Dial Transplant 2012, 27:1574-1579.
26. Henne W.D.G., Schmitz W, Pohle R, Lawitzki F, Dialyzing membrane with adsorbent layer. US patent No 4267047; 1981.
27. Chapman G.V., Hone P.W.E., Shirlow M.J. Evaluation of hemodiafiltration and sorbent membrane dialysis: II. Clinical, nutritional, and middle molecule assessment. Dial Transplant 1982, 11:871-876.
28. Maeda K., Saito A., Kawaguchi S. Problems with activated charcoal and alumina as sorbents for medical use. Artif Organs 1979, 3:336-340.
29. Chapman G.V., Hone P.W.E., Bolton W., Blogg A., Stokoe C., Cahill T., et al. Evaluation of hemodiafiltration and sorbent membrane dialysis 1. Invivo and invitro dialyzer performance. Dial Transplant 1982, 11:758-765.
30. Vienken J., Diamantoglou M., Henne W., Nederlof B. Artificial dialysis membranes: from concept to large scale production. Am J Nephrol 1999, 19:355-362.
31. Tijink M.S.L., Wester M., Sun J., Saris A., Bolhuis-Versteeg L.A.M., Saiful S., et al. Anovel approach for blood purification: mixed-matrix membranes combining diffusion and adsorption in one step. Acta Biomater 2012, 8:2279-2287.
32. Su B.H., Fu P., Li Q., Tao Y., Li Z., Zao H.S., et al. Evaluation of polyethersulfone highflux hemodialysis membrane invitro and invivo. JMater Sci Mater Med 2008, 19:745-751.
33. Zweigart C., Neubauer M., Storr M., Böhler T., Krause B. Progress in the development of membranes for kidney-replacement therapy. Comprehensive membrane science and engineering 2010, 351-390. Elsevier, Oxford. D. Enrico, G. Lidietta (Eds.).
34. Ash S.R. Sorbents in treatment of uremia: a short history and a great future. Semin Dial 2009, 22:615-622.
35. Feigenbaum J., Neuberg C.A. Simplified method for the preparation of aromatic sulfuric acid esters. JAm Chem Soc 1941, 63:3529-3530.
36. Vanholder R., De Smet R., Glorieux G., Argiles A., Baurmeister U., Brunet P., et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003, 63:1934-1943.
37. Meert N., Eloot S., Waterloos M.A., Van Landschoot M., Dhondt A., Glorieux G., et al. Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. Nephrol Dial Transplant 2009, 24:562-570.
38. Meert N., Schepers E., Glorieux G., Van Landschoot M., Goeman J.L., Waterloos M.A., et al. Novel method for simultaneous determination of p-cresyl sulphate and p-cresyl glucuronide: clinical data and pathophysiological implications. Nephrol Dial Transplant 2012, 27:2388-2396.
39. Boom R.M. Membrane formation by immersion precipitation: the role of a polymeric additive 1992, [Ph.D. thesis], University of Twente, Enschede.
40. Xu Z.L., Qusay F.A. Polyethersulfone (PES) hollow fiber ultrafiltration membranes prepared by PES/non-solvent/NMP solution. JMembr Sci 2004, 233:101-111.
41. Yang Q., Chung T.S., Weber M. Microscopic behavior of polyvinylpyrrolidone hydrophilizing agents on phase inversion polyethersulfone hollow fiber membranes for hemofiltration. JMembr Sci 2009, 326:322-331.
42. Liu Y., Koops G.H., Strathmann H. Characterization of morphology controlled polyethersulfone hollow fiber membranes by the addition of polyethylene glycol to the dope and bore liquid solution. JMembr Sci 2003, 223:187-199.
43. Barzin J., Feng C., Khulbe K.C., Matsuura T., Madaeni S.S., Mirzadeh H. Characterization of polyethersulfone hemodialysis membrane by ultrafiltration and atomic force microscopy. JMembr Sci 2004, 237:77-85.
44. Liao Z., Klein E., Poh C.K., Huang Z., Lu J., Hardy P.A., et al. Measurement of hollow fiber membrane transport properties in hemodialyzers. JMembr Sci 2005, 256:176-183.
45. Deng X., Wang T., Zhao F., Li L., Zhao C. Poly(ether sulfone)/activated carbon hybrid beads for creatinine adsorption. JAppl Polym Sci 2007, 103:1085-1092.
46. Ye C., Gong Q.M., Lu F.P., Liang J. Adsorption of uraemic toxins on carbon nanotubes. Sep Purif Tech 2007, 58:2-6.
47. Gao B., Yang Y., Wang J., Zhang Y. Preparation and adsorption characteristic of polymeric microsphere with strong adsorbability for creatinine. JBiochem Mol Toxicol 2008, 22:166-174.
48. Tetala K.K.R., Stamatialis D.F. Mixed matrix membranes for efficient adsorption of copper ions from aqueous solutions. Sep Purif Tech 2013, 104:214-220.
49. Martinez A.W., Recht N.S., Hostetter T.H., Meyer T.W. Removal of p-cresol sulfate by hemodialysis. JAm Soc Nephrol 2005, 16:3430-3436.